Patents by Inventor Peter G. Bakhit

Peter G. Bakhit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8858961
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Grant
    Filed: June 11, 2009
    Date of Patent: October 14, 2014
    Assignee: Allergan, Inc.
    Inventors: Richard S. Graham, Peter G. Bakhit, Orest Olejnik
  • Publication number: 20090312337
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Application
    Filed: June 11, 2009
    Publication date: December 17, 2009
    Applicant: ALLERGAN, INC.
    Inventors: Richard S. Graham, Peter G. Bakhit, Orest Olejnik
  • Patent number: 7332526
    Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.
    Type: Grant
    Filed: June 12, 2007
    Date of Patent: February 19, 2008
    Assignee: Allergan, Inc.
    Inventors: Peter G. Bakhit, Richard Graham, Orest Olejnik
  • Patent number: 7244768
    Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.
    Type: Grant
    Filed: August 25, 2004
    Date of Patent: July 17, 2007
    Assignee: Allergan, Inc.
    Inventors: Peter G. Bakhit, Richard Graham, Orest Olejnik
  • Patent number: 6984628
    Abstract: This invention relates to compositions comprising trefoil family factor peptides which are useful in preventing or treating dry eye by topical administration of the composition to eye of the patient. One aspect of this invention relates to topical ophthalmic compositions comprising a trefoil factor family peptide, and preferably, a mucoadhesive component, as described herein. Another aspect of this invention relates to the use of these compositions to treat or prevent dry eye in a patient.
    Type: Grant
    Filed: July 15, 2003
    Date of Patent: January 10, 2006
    Assignee: Allergan, Inc.
    Inventors: Peter G. Bakhit, Orest Olejnik, Richard Graham
  • Patent number: 6165415
    Abstract: A system for disinfecting a contact lens includes a first container section holding a first liquid medium containing hydrogen peroxide. A second container section is provided and holds a second liquid medium containing a hydrogen peroxide destroying component. The first and second container sections are configured to substantially simultaneously provide the first liquid medium and the second liquid medium to form a combined liquid medium containing an amount of hydrogen peroxide from the first liquid medium effective to disinfect a contact lens contacted with the combined liquid medium and an amount of hydrogen peroxide destroying component from the second liquid medium effective to destroy at least a major amount of the hydrogen peroxide in the combined liquid medium.
    Type: Grant
    Filed: October 26, 1998
    Date of Patent: December 26, 2000
    Assignee: Allergan
    Inventors: Terrence J. Hunt, Peter G. Bakhit
  • Patent number: 6022732
    Abstract: Compositions, and methods for using such compositions, which are useful to destroy hydrogen peroxide in a liquid aqueous medium, such as that used to disinfect contact lenses. In one embodiment, the composition comprises a hydrogen peroxide destroying component effective when released in a hydrogen peroxide-containing liquid aqueous medium to destroy or cause the destruction of hydrogen peroxide present in the hydrogen peroxide-containing liquid aqueous medium, and a barrier component acting to substantially prevent the release of the hydrogen peroxide destroying component for a period of time after the composition is initially contacted with the hydrogen peroxide-containing liquid aqueous medium, the barrier component comprising a material selected from the group consisting of water soluble cellulose derivatives and mixtures thereof having a molecular weight of at least about 20,000.
    Type: Grant
    Filed: April 9, 1997
    Date of Patent: February 8, 2000
    Assignee: Allergan
    Inventors: Peter G. Bakhit, Terrence J. Hunt, Michael B. Shah
  • Patent number: 5897833
    Abstract: A system for disinfecting a contact lens includes a first container section holding a first liquid medium containing hydrogen peroxide. A second container section is provided and holds a second liquid medium containing a hydrogen peroxide destroying component. The first and second container sections are configured to substantially simultaneously provide the first liquid medium and the second liquid medium to form a combined liquid medium containing an amount of hydrogen peroxide from the first liquid medium effective to disinfect a contact lens contacted with the combined liquid medium and an amount of hydrogen peroxide destroying component from the second liquid medium effective to destroy at least a major amount of the hydrogen peroxide in the combined liquid medium.
    Type: Grant
    Filed: September 30, 1996
    Date of Patent: April 27, 1999
    Assignee: Allergan
    Inventors: Terrence J. Hunt, Peter G. Bakhit